comparemela.com

Latest Breaking News On - Stem cell research fund - Page 1 : comparemela.com

4 mid-Atlantic orgs supporting innovation and new tech

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes

SUNNYVALE, Calif., Dec. 18, 2023 BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.